Oxykodon 30 mg

Oxycodone HCl 30mg – High-Potency Opioid for Severe Chronic Pain
(Extended-Release Formulation – Reserved for Opioid-Tolerant Patients Only)

⚠️ Critical Safety Notice

• STRICTLY CONTRAINDICATED for opioid-naïve individuals

• FOR USE ONLY in patients already taking ≥45mg MEDD (morphine equivalent daily dose)

• TAMPERING RISK: Must prescribe with abuse-deterrent formulation

Terapeutický profil

• Schedule II controlled substance (DEA)
• Trvání: 12hodinové řízené uvolňování
• Vrcholový efekt: 4-6 hours post-dose
• Metabolismus: Hepatic (CYP3A4/2D6)

FDA-Approved Indications

✔ Around-the-clock cancer pain management
✔ Chronic severe pain in opioid-adapted patients
✔ Palliative care when lower doses fail

Dávkovací protokol

• Minimum Tolerance Requirement:
  ≥45mg oral morphine equivalents/day for ≥1 week

• Conversion Guide:
  30mg oxycodone ER q12h = 60mg oral morphine/day

• Správa:
  Swallow whole – never crush, chew, or dissolve

• Renal Adjustment:
  Reduce frequency to q24h if CrCl <30mL/min

Abuse-Deterrent Features

• Hardened Tablet Matrix (resists crushing)

• Viscous Gel Formation if manipulated

• Brand Examples: OxyContin OP, Xtampza ER

Varování černé skříňky

🛑 VYSOKÝ POTENCIÁL ZÁVISLOSTI – Abuse may lead to overdose/death
🛑 ŽIVOT OHROŽUJÍCÍ RESPIRAČNÍ DEPRESE
🛑 NEONATAL OPIOID WITHDRAWAL SYNDROME

Prescribing Requirements

• Documented Opioid Tolerance in medical record
• Pain Management Contract signed
• Současný předpis s naloxonem mandatory
• Monthly PDMP Checks požadovaný

Identification & Packaging

• Tablet Markings:
  • OxyContin OP: “OP” on one side, “30” on other
  • Colors vary by manufacturer (e.g., green, gray)

• Dispensing Limits:
  • 30-day supply maximum
  • No automatic refills